Mina Tadrous, PharmD, PhD, MS

Assistant Professor
University of Toronto, Canada

Poster(s):

• (320) Association Between Oral Corticosteroid Prescribing Patterns and Appropriate Fracture Preventive Care in People with Atopic Eczema in the UK
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (R) Agreement and Correlation Between Different Topical Corticosteroid Potency Classification Systems
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (91) Global Extent of The Valsartan Drug Recall and Its Effect on Antihypertensive Drug Use: A Multi-National Study
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (89) Impact of the COVID-19 Controlled Drugs and Substances Act Exemption on Pharmacist Prescribing of Opioids and Benzodiazepines in Ontario: A Cross-Sectional Time-Series Analysis
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (90) International Trends in Prescription Opioid Sales Among Developed and Developing Countries Prior To, and During The COVID-19 Pandemic: A Cross-Sectional Analysis of 66 Countries
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (288) Risk of SARS-CoV-2 Infection Following Initial COVID-19 Vaccination by Location
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (106) The Effects of Virtual Care Use on Prescription Drug Claims Among Older Adults with Dementia Before and During COVID-19
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (61) The Impact of Expanded Access to Direct Acting Antivirals for Hepatitis C on Patient Outcomes in Canada
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST